Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Škrha

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Nature Communications|January 11, 2022
Lipidomic profiling of human serum enables detection of pancreatic cancerDenise Wolrab, Robert Jirásko, Eva Cífková, et al.
Nature Communications|February 4, 2022
The IGFBP3/TMEM219 pathway regulates beta cell homeostasisFrancesca D'Addio, Anna Maestroni, Emma Assi, et al.
Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Cardiovascular Diabetology|March 20, 2024
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomesOliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Nature Communications|January 11, 2022
Lipidomic profiling of human serum enables detection of pancreatic cancerDenise Wolrab, Robert Jirásko, Eva Cífková, et al.
Nature Communications|February 4, 2022
The IGFBP3/TMEM219 pathway regulates beta cell homeostasisFrancesca D'Addio, Anna Maestroni, Emma Assi, et al.
Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Cardiovascular Diabetology|March 20, 2024
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomesOliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, et al.
Pageof 5